The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Integration of EGFR inhibitors with radiochemotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486 · cited 1×
“Two clinical studies found that gefitinib caused significant tumour regression in a small subset of non-smoker, female patients from Japan with adenocarcinoma of the lun”
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Pignon, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90011-0 · Cited by 2,543
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Tsao, M.-S., Sakurada, A., Cutz, J.-C., Zhu, C.-Q., Kamel-Reid, S., Squire, J., Lorimer, I., Zhang, T., Liu, N., Daneshmand, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050736 · Cited by 1,830
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Giaccone, G., Herbst, R. S., Manegold, C., Scagliotti, G., Rosell, R., Miller, V., Natale, R. B., Schiller, J. H., von Pawel, J., Pluzanska, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.001 · Cited by 1,716
Herbst, R. S., Giaccone, G., Schiller, J. H., Natale, R. B., Miller, V., Manegold, C., Scagliotti, G., Rosell, R., Oliff, I., Reeves, J. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.215 · Cited by 1,707
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Stamos, J., Sliwkowski, M. X., & Eigenbrot, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207135200 · Cited by 1,574
Cappuzzo, F., Hirsch, F. R., Rossi, E., Bartolini, S., Ceresoli, G. L., Bemis, L., Haney, J., Witta, S., Danenberg, K., Domenichini, I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji112 · Cited by 1,551
Herbst, R. S., Prager, D., Hermann, R., Fehrenbacher, L., Johnson, B. E., Sandler, A., Kris, M. G., Tran, H. T., Klein, P., Li, X., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.840 · Cited by 1,490
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Ang, K. K., Berkey, B. A., Tu, X., Zhang, H. Z., Katz, R. L., Hammond, E. H., Fu, K. K., & Milas, L. (2002) · PubMed · Cited by 1,198
Targeting the mitogen-activated protein kinase cascade to treat cancer
Sebolt-Leopold, J. S., & Herrera, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1503 · Cited by 1,108
Chung, K. Y., Shia, J., Kemeny, N. E., Shah, M., Schwartz, G. K., Tse, A., Hamilton, A., Pan, D., Schrag, D., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.037 · Cited by 1,081
Buday, L., & Downward, J. (1993) · Cell · doi:10.1016/0092-8674(93)90146-h · Cited by 1,079
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Ciardiello, F., Caputo, R., Bianco, R., Damiano, Pomatico, G., De Placido, S., Bianco, A. R., & Tortora, G. (2000) · PubMed · Cited by 943
Dillman, R. O., Herndon, J., Seagren, S. L., Eaton, W. L., & Green, M. R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1210 · Cited by 923
Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
Gordon Steel, G., & Peckham, M. J. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90044-0 · Cited by 908
Burtness, B., Goldwasser, M. A., Flood, W., Mattar, B., & Forastiere, A. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4646 · Cited by 879
Goldstein, N. I., Prewett, M. C., Zuklys, K., Rockwell, P., & Mendelsohn, J. M. (1995) · PubMed · Cited by 785
Sirotnak, F. M., Zakowski, M. F., Miller, V. A., Scher, H. I., & Kris, M. G. (2000) · PubMed · Cited by 761
Huang, S., Bock, J. M., & Harari, P. M. (1999) · PubMed · Cited by 714
Takano, T., Ohe, Y., Sakamoto, H., Tsuta, K., Matsuno, Y., Tateishi, U., Yamamoto, S., Nokihara, H., Yamamoto, N., Sekine, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.0793 · Cited by 695
Biscardi, J. S., Maa, M.-C., Tice, D. A., Cox, M. E., Leu, T.-H., & Parsons, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8335 · Cited by 649
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G. R., Zoltick, P. W., Biegel, J. A., Hayes, R. L., & Wong, A. J. (1995) · PubMed · Cited by 637
Burris, H. A., Hurwitz, H. I., Dees, E. C., Dowlati, A., Blackwell, K. L., O'Neil, B., Marcom, P. K., Ellis, M. J., Overmoyer, B., Jones, S. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.584 · Cited by 619
Hirsch, F. R., Varella-Garcia, M., McCoy, J., West, H., Xavier, A. C., Gumerlock, P., Bunn, P. A., Franklin, W. A., Crowley, J., & Gandara, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.2823 · Cited by 574
Huang, S., & Harari, P. M. (2000) · PubMed · Cited by 555
Bell, D. W., Gore, I., Okimoto, R. A., Godin-Heymann, N., Sordella, R., Mulloy, R., Sharma, S. V., Brannigan, B. W., Mohapatra, G., Settleman, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1671 · Cited by 531
Dittmann, K., Mayer, C., Fehrenbacher, B., Schaller, M., Raju, U., Milas, L., Chen, D. J., Kehlbach, R., & Rodemann, H. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506591200 · Cited by 529
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Milas, L., Mason, K. A., Hunter, N. R., et al. (2000) · PubMed · Cited by 503
Robert, F., Ezekiel, M. P., Spencer, S. A., Meredith, R. F., Bonner, J. A., Khazaeli, M. B., Saleh, M. N., Carey, D., LoBuglio, A. F., Wheeler, R. H., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3234 · Cited by 474
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
Yang, X. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00134-7 · Cited by 463
Fan, Z., Baselga, J. M., Masui, H., & Mendelsohn, J. M. (1993) · PubMed · Cited by 456
FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets
Cohen, M. H., Johnson, J. R., Chen, Y.-F., Sridhara, R., & Pazdur, R. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-461 · Cited by 445
Fry, D. W., Bridges, A. J., Denny, W. A., Doherty, A., Greis, K. D., Hicks, J. L., Hook, K. E., Keller, P. R., Leopold, W. R., Loo, J. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.12022 · Cited by 418
Schmidt-Ullrich, R. K., Mikkelsen, R. B., Dent, P., Todd, D. G., Valerie, K., Kavanagh, B. D., Contessa, J. N., Rorrer, W. K., & Chen, P. B. (1997) · Oncogene · doi:10.1038/sj.onc.1201275 · Cited by 412
Baselga, J., Norton, L., Masui, H., Pandiella, A., Coplan, K., Miller, W. H., & Mendelsohn, J. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.16.1327 · Cited by 411
Jänne, P. A., Engelman, J. A., & Johnson, B. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.985 · Cited by 405
Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR)
Huang, S., Armstrong, E. A., Benavente, S., Chinnaiyan, P., & Harari, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0562 · Cited by 366
Akimoto, T., Hunter, N. R., Buchmiller, L., Mason, K. A., Ang, K. K., & Milas, L. (1999) · PubMed · Cited by 357
Rowinsky, E. K., Schwartz, G. H., Gollob, J. A., Thompson, J. A., Vogelzang, N. J., Figlin, R., Bukowski, R., Haas, N., Lockbaum, P., Li, Y.-P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.061 · Cited by 329
Dent, P., Reardon, D. B., Park, J. S., Bowers, G., Logsdon, C., Valerie, K., & Schmidt-Ullrich, R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.8.2493 · Cited by 326
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
Dittmann, K., Mayer, C., & Rodemann, H.-P. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.022 · Cited by 287
Peng, D., Fan, Z., Yang, L., DeBlasio, T., Scher, H. I., & Mendelsohn, J. M. (1996) · PubMed · Cited by 280
Matar, P., Rojo, F., Cassia, R., Moreno-Bueno, G., Di Cosimo, S., Tabernero, J., Guzmán, M., Rodriguez, S., Arribas, J., Palacios, J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0870 · Cited by 277
Nakagawa, K., Tamura, T., Negoro, S., Kudoh, S., Yamamoto, N., Yamamoto, N., Takeda, K., Swaisland, H., Nakatani, I., Hirose, M., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg250 · Cited by 277
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
de Palazzo, I. G., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., & Weiner, L. M. (1993) · PubMed · Cited by 269
Epidermal growth factor receptor tyrosine kinase
Ward, W. H. J., Cook, P. N., Slater, A. M., Davies, D. H., Holdgate, G. A., & Green, L. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90042-6 · Cited by 261
Vanhoefer, U., Tewes, M., Rojo, F., Dirsch, O., Schleucher, N., Rosen, O., Tillner, J., Kovar, A., Braun, A. H., Trarbach, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.114 · Cited by 261
Wu, X., Rubin, M., Fan, Z., DeBlasio, T., Soos, T. J., Koff, A., & Mendelsohn, J. M. (1996) · PubMed · Cited by 228
Bonner, J. A., Raisch, K. P., Trummell, H. Q., et al. (2000) · PubMed · Cited by 220
Boerner, J. L., Demory, M. L., Silva, C., & Parsons, S. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7059-7071.2004 · Cited by 213
Cappuzzo, F., Gregorc, V., Rossi, E., Cancellieri, A., Magrini, E., Paties, C. T., Ceresoli, G., Lombardo, L., Bartolini, S., Calandri, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.039 · Cited by 212
Harari, P. M., & Huang, S. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01488-7 · Cited by 208
Busse, D., Doughty, R. S., Ramsey, T. T., Russell, W. E., Price, J. O., Flanagan, W. M., Shawver, L. K., & Arteaga, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6987 · Cited by 205
Parra, H. S., Cavina, R., Latteri, F., Zucali, P. A., Campagnoli, E., Morenghi, E., Grimaldi, G. C., Roncalli, M., & Santoro, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601923 · Cited by 201
Grøvdal, L. M., Stang, E., Sorkin, A., & Madshus, I. H. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.003 · Cited by 182
Epidermal growth factor receptor
Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P. J., Ward, C. W., & Burgess, A. W. (2003) · The EGF Receptor Family · doi:10.1016/b978-012160281-9/50004-9 · Cited by 181
Tan, A. R., Yang, X., Hewitt, S. M., Berman, A., Lepper, E. R., Sparreboom, A., Parr, A. L., Figg, W. D., Chow, C., Steinberg, S. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.189 · Cited by 176
Epidermal Growth Factor Receptor Family and Chemosensitization
Mendelsohn, J., & Fan, Z. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.5.341 · Cited by 171
Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck
Sheridan, M. T., O’Dwyer, T. P., Seymour, C. B., & Mothersill, C. E. (1997) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1997)5:4<180::aid-roi3>3.0.co;2-u · Cited by 162
Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies
Milas, L., Fan, Z., Andratschke, N. H., & Ang, K. K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.08.035 · Cited by 162
Keilhack, H., Tenev, T., Nyakatura, E., Godovac-Zimmermann, J., Nielsen, L., Seedorf, K., & Böhmer, F.-D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24839 · Cited by 160
Han, S., Hwang, P. G., Chung, D. H., Kim, D., Im, S., Kim, Y. T., Kim, T., Heo, D. S., Bang, Y., & Kim, N. K. (2004) · International Journal of Cancer · doi:10.1002/ijc.20550 · Cited by 159
Cisplatin-induced activation of the EGF receptor
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205980 · Cited by 156
Saleh, M. N., Raisch, K. P., Stackhouse, M. A., et al. (1999) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1999.14.451 · Cited by 154
Bowers, G. D., Reardon, D. B., Hewitt, T., Dent, P., Mikkelsen, R. B., Valerie, K. C., Lammering, G., Amir, C., & Schmidt‐Ullrich, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204255 · Cited by 153
Contessa, J. N., Hampton, J. L., Lammering, G., Mikkelsen, R. B., Dent, P., Valerie, K. C., & Schmidt‐Ullrich, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205500 · Cited by 153
Balaban, N., Moni, J., Shannon, M., Dang, L. B., Murphy, E., & Goldkorn, T. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(96)00068-7 · Cited by 148
Gennaro, E. D., Barbarino, M., Bruzzese, F., Lorenzo, S. D., Caraglia, M., Abbruzzese, A., Avallone, A., Comella, P., Caponigro, F., Pepe, S., et al. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10239 · Cited by 141
Moore, M. J., Goldstein, D., Hamm, J. T., Figer, A., Hecht, J., Gallinger, S., Au, H., Ding, K., Christy-Bittel, J., & Parulekar, W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.1 · Cited by 140
Segaert, S., Tabernero, J. M., Chosidow, O., Dirschka, T., Elsner, J., Mancini, L. L., Maughan, T., Morère, J., Santoro, A., Sobrero, A. F., et al. (2005) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2005.05058.x · Cited by 137
Treatment of cancer with radiation and drugs.
Tannock, I. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3156 · Cited by 135
Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation
Choong, N. W., Dietrich, S., Seiwert, T. Y., Tretiakova, M., Nallasura, V., Davies, G. C., Lipkowitz, S., Husain, A. N., Salgia, R., & Ma, P. C. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0400 · Cited by 126
Solomon, B., Hagekyriakou, J., Trivett, M. K., Stacker, S. A., McArthur, G. A., & Cullinane, C. M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04357-2 · Cited by 118
Rao, G., Murray, S., & Ethier, S. P. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01358-4 · Cited by 117
Schaeybroeck, S. V., Karaïskou, A., Kelly, D. M., Longley, D. B., Galligan, L., Cutsem, E. V., & Johnston, P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0328 · Cited by 116
Morelli, M. P., Cascone, T., Troiani, T., Vita, F. D., Orditura, M., Laus, G., Eckhardt, S. G., Pepe, S., Tortora, G., & Ciardiello, F. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi910 · Cited by 112
Campos, S. M., Hamid, O., Seiden, M. V., Oza, A. M., Plante, M., Potkul, R. K., Lenehan, P. F., Kaldjian, E. P., Varterasian, M. L., Jordan, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.091 · Cited by 106
Friedmann, B. J., Caplin, M. E., Savic, B., Shah, T., Lord, C. J., Ashworth, A., Hartley, J. A., & Hochhauser, D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0239 · Cited by 103
Modulation of molecular targets to enhance radiation.
Harari, P. M., & Huang, S. (2000) · PubMed · Cited by 103
Modjtahedi, H., Hickish, T., Nicolson, M. C., Moore, J. L., Styles, J., Eccles, S. A., Jackson, E., Salter, J., Sloane, J., Spencer, L., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.40 · Cited by 101
Bonner, J. A., Maihle, N. J., Folven, B. R., et al. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90269-0 · Cited by 98
Russo, M. W., Lukas, T. J., Cohen, S., & Staros, J. V. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89002-0 · Cited by 95
Shintani, S., Li, C., Mihara, M., Terakado, N., Yano, J., Nakashiro, K., & Hamakawa, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11437 · Cited by 95
Kollmannsberger, C., Schittenhelm, M. M., Honecker, F. U., Tillner, J., Weber, D., Oechsle, K., Kanz, L., & Bokemeyer, C. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl042 · Cited by 94
Goldberg, R. M., & Kirkpatrick, P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1728 · Cited by 90
Phase 1 Clinical and Pharmacokinetics Evaluation of Oral CI-1033 in Patients with Refractory Cancer
Nemunaitis, J. J., Eiseman, I. A., Cunningham, C. C., Senzer, N. N., Williams, A., Lenehan, P. F., Olson, S. C., Bycott, P. W., Schlicht, M., Zentgraff, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1950 · Cited by 88
Radiosensitization by Pan ErbB Inhibitor CI-1033 in Vitro and in Vivo
Nyati, M. K., Maheshwari, D., Hanasoge, S., Sreekumar, A., Rynkiewicz, S. D., Chinnaiyan, A. M., Leopold, W. R., Ethier, S. P., & Lawrence, T. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1041-03 · Cited by 86
Self-citationYoshimura, N., Kudoh, S., Kimura, T., Mitsuoka, S., Matsuura, K., Hirata, K., Matsui, K., Negoro, S., Nakagawa, K., & Fukuoka, M. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.10.006 · Cited by 81
Calvo, E., Tolcher, A. W., Hammond, L. A., Patnaik, A., Bono, J. S. D., Eiseman, I. A., Olson, S. C., Lenehan, P. F., McCreery, H., LoRusso, P. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1187 · Cited by 81
Friedmann, B. J., Caplin, M. E., Hartley, J. A., & Hochhauser, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0586 · Cited by 79
Synergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck Carcinoma
Chun, P. Y., Feng, F. Y.-C., Scheurer, A. M., Davis, M. A., Lawrence, T. S., & Nyati, M. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2665 · Cited by 76
Self-citationLi, J., Lin, M., Wiepz, G. J., Guadarrama, A. G., & Bertics, P. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11209 · Cited by 76
Boerner, J. L., Biscardi, J. S., Silva, C. M., & Parsons, S. J. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20138 · Cited by 74
Laux, I., Jain, A., Singh, S., & Agus, D. B. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602875 · Cited by 70
Brief Communication: A New Combination in the Treatment of Advanced Pancreatic Cancer
Moore, M. J. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.017 · Cited by 64
Baselga, J. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.903 · Cited by 63
Sumitomo, M., Asano, T., Asakuma, J., Asano, T., Horiguchi, A., & Hayakawa, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0948-03 · Cited by 57
Hagan, M. P., Yacoub, A., & Dent, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0420 · Cited by 55
Johnson, B. E., & Janne, P. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.97.008 · Cited by 55
Azzariti, A., Xu, J.-M., Porcelli, L., & Paradiso, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.014 · Cited by 53
PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors
Oliva, J. L., Oliva, J. L., Griner, E., Oliva, J. L., Griner, E., & Kazanietz, M. G. (2005) · Growth Factors · doi:10.1080/08977190500366043 · Cited by 53
Elie, C., Geay, J.-F., Morcos, M., Tourneau, A. L., Girre, V., Broët, P., Marmey, B., Chauvenet, L., Audouin, J., Pujade-Lauraine, É., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601961 · Cited by 50
Gullick, W. J., Downward, J., Parker, P. J., Whittle, N., Kris, R., Schlessinger, J., Ullrich, A., & Waterfield, M. D. (1985) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1985.0087 · Cited by 42
Hoekstra, R., Dumez, H., Eskens, F. A. L. M., van der Gaast, A., Planting, A. S. T., de Heus, G., Sizer, K. C., Ravera, C., Vaidyanathan, S., Bucana, C. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0720 · Cited by 39
Abdelmohsen, K., von Montfort, C., Stuhlmann, D., Gerber, P. A., Decking, U. K. M., Sies, H., & Klotz, L. (2005) · Biological Chemistry · doi:10.1515/bc.2005.027 · Cited by 27
Gullick, W. J., Downward, J., Foulkes, J. G., & Waterfield, M. D. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09744.x · Cited by 26
Dowell, J. E., Caplan, N. M., & Palmer, B. F. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200603000-00006 · Cited by 15
Cited by
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Biological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K.-W. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 638
Hatanpaa, K. J., Burma, S., Zhao, D., & Habib, A. A. (2010) · Neoplasia · doi:10.1593/neo.10688 · Cited by 471
Innovations in image-guided radiotherapy
Verellen, D., Ridder, M. D., Linthout, N., Tournel, K., Soete, G., & Storme, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2288 · Cited by 384
Oncogenic EGFR Signaling Networks in Glioma
Huang, P. H., Xu, A. M., & White, F. M. (2009) · Science Signaling · doi:10.1126/scisignal.287re6 · Cited by 363
Metadata
- Authors
- Nyati, M. K., Morgan, M. A., Feng, F. Y., & Lawrence, T. S.
- Venue
- Nature Reviews Cancer
- Published
- 2006-10-12
- Volume
- 6
- Issue
- 11
- Pages
- 876-885
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2037395954
- Cited by
- 304
- References
- 124
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.